Literature DB >> 24135949

EIF2AK4 mutations in pulmonary capillary hemangiomatosis.

D Hunter Best1, Kelli L Sumner2, Eric D Austin3, Wendy K Chung4, Lynette M Brown5, Alain C Borczuk6, Erika B Rosenzweig4, Pinar Bayrak-Toydemir2, Rong Mao2, Barbara C Cahill7, Henry D Tazelaar8, Kevin O Leslie8, Anna R Hemnes9, Ivan M Robbins9, C Gregory Elliott10.   

Abstract

BACKGROUND: Pulmonary capillary hemangiomatosis (PCH) is a rare disease of capillary proliferation of unknown cause and with a high mortality. Families with multiple affected individuals with PCH suggest a heritable cause although the genetic etiology remains unknown.
METHODS: We used exome sequencing to identify a candidate gene for PCH in a family with two affected brothers. We then screened 11 unrelated patients with familial (n = 1) or sporadic (n = 10) PCH for mutations.
RESULTS: Using exome sequencing, we identified compound mutations in eukaryotic translation initiation factor 2 α kinase 4 (EIF2AK4) (formerly known as GCN2) in both affected brothers. Both parents and an unaffected sister were heterozygous carriers. In addition, we identified two EIF2AK4 mutations in each of two of 10 unrelated individuals with sporadic PCH. EIF2AK4 belongs to a family of kinases that regulate angiogenesis in response to cellular stress.
CONCLUSIONS: Mutations in EIF2AK4 are likely to cause autosomal-recessive PCH in familial and some nonfamilial cases.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24135949      PMCID: PMC3921094          DOI: 10.1378/chest.13-2366

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  17 in total

1.  The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data.

Authors:  Aaron McKenna; Matthew Hanna; Eric Banks; Andrey Sivachenko; Kristian Cibulskis; Andrew Kernytsky; Kiran Garimella; David Altshuler; Stacey Gabriel; Mark Daly; Mark A DePristo
Journal:  Genome Res       Date:  2010-07-19       Impact factor: 9.043

2.  How do tumours adapt to nutrient stress?

Authors:  Ronald C Wek; Kirk A Staschke
Journal:  EMBO J       Date:  2010-06-16       Impact factor: 11.598

Review 3.  Updated clinical classification of pulmonary hypertension.

Authors:  Gérald Simonneau; Ivan M Robbins; Maurice Beghetti; Richard N Channick; Marion Delcroix; Christopher P Denton; C Gregory Elliott; Sean P Gaine; Mark T Gladwin; Zhi-Cheng Jing; Michael J Krowka; David Langleben; Norifumi Nakanishi; Rogério Souza
Journal:  J Am Coll Cardiol       Date:  2009-06-30       Impact factor: 24.094

Review 4.  Pulmonary capillary hemangiomatosis. A report of three cases and a review of the literature.

Authors:  C N Faber; S A Yousem; J H Dauber; B P Griffith; R L Hardesty; I L Paradis
Journal:  Am Rev Respir Dis       Date:  1989-09

5.  Characterization of a mammalian homolog of the GCN2 eukaryotic initiation factor 2alpha kinase.

Authors:  J J Berlanga; J Santoyo; C De Haro
Journal:  Eur J Biochem       Date:  1999-10

6.  A novel channelopathy in pulmonary arterial hypertension.

Authors:  Lijiang Ma; Danilo Roman-Campos; Eric D Austin; Mélanie Eyries; Kevin S Sampson; Florent Soubrier; Marine Germain; David-Alexandre Trégouët; Alain Borczuk; Erika Berman Rosenzweig; Barbara Girerd; David Montani; Marc Humbert; James E Loyd; Robert S Kass; Wendy K Chung
Journal:  N Engl J Med       Date:  2013-07-25       Impact factor: 91.245

Review 7.  Pulmonary capillary hemangiomatosis imaging findings and literature update.

Authors:  Mohamed El-Gabaly; Carol F Farver; Marie A Budev; Tan-Lucien H Mohammed
Journal:  J Comput Assist Tomogr       Date:  2007 Jul-Aug       Impact factor: 1.826

Review 8.  Pulmonary capillary hemangiomatosis: a clinicopathologic review.

Authors:  M A Eltorky; A S Headley; H Winer-Muram; H E Garrett; J P Griffin
Journal:  Ann Thorac Surg       Date:  1994-03       Impact factor: 4.330

9.  Familial pulmonary capillary hemangiomatosis resulting in primary pulmonary hypertension.

Authors:  D Langleben; J M Heneghan; A P Batten; N S Wang; N Fitch; R D Schlesinger; A Guerraty; J L Rouleau
Journal:  Ann Intern Med       Date:  1988-07-15       Impact factor: 25.391

10.  Familial pulmonary capillary hemangiomatosis early in life.

Authors:  Johannes Wirbelauer; Helge Hebestreit; Alexander Marx; Eugene J Mark; Christian P Speer
Journal:  Case Rep Pulmonol       Date:  2011-12-19
View more
  60 in total

1.  Mouse Genome-Wide Association Study of Preclinical Group II Pulmonary Hypertension Identifies Epidermal Growth Factor Receptor.

Authors:  Neil J Kelly; Josiah E Radder; Jeffrey J Baust; Christine L Burton; Yen-Chun Lai; Karin C Potoka; Brittani A Agostini; John P Wood; Timothy N Bachman; Rebecca R Vanderpool; Nadine Dandachi; Adriana S Leme; Alyssa D Gregory; Alison Morris; Ana L Mora; Mark T Gladwin; Steven D Shapiro
Journal:  Am J Respir Cell Mol Biol       Date:  2017-04       Impact factor: 6.914

2.  Meta-analysis of blood genome-wide expression profiling studies in pulmonary arterial hypertension.

Authors:  Jason M Elinoff; Adrien J Mazer; Rongman Cai; Mengyun Lu; Grace Graninger; Bonnie Harper; Gabriela A Ferreyra; Junfeng Sun; Michael A Solomon; Robert L Danner
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-10-16       Impact factor: 5.464

3.  ERG-APLNR axis controls pulmonary venule endothelial proliferation in pulmonary veno-occlusive disease.

Authors:  Christopher Lathen; Yu Zhang; Jennifer Chow; Martanday Singh; Grace Lin; Vishal Nigam; Yasser A Ashraf; Jason X Yuan; Ivan M Robbins; Patricia A Thistlethwaite
Journal:  Circulation       Date:  2014-07-25       Impact factor: 29.690

4.  Pulmonary capillary hemangiomatosis: a case series and review of literature.

Authors:  Mahmoud Abdelnabi; Abdallah Almaghraby; Hoda Abdelgawad; Fatma Elkafrawy; Karim Ziada
Journal:  Am J Cardiovasc Dis       Date:  2021-04-15

5.  Critical Genomic Networks and Vasoreactive Variants in Idiopathic Pulmonary Arterial Hypertension.

Authors:  Anna R Hemnes; Min Zhao; James West; John H Newman; Stuart Rich; Stephen L Archer; Ivan M Robbins; Timothy S Blackwell; Joy Cogan; James E Loyd; Zhongming Zhao; Christa Gaskill; Christopher Jetter; Jonathan A Kropski; Susan M Majka; Eric D Austin
Journal:  Am J Respir Crit Care Med       Date:  2016-08-15       Impact factor: 21.405

Review 6.  The genetics of pulmonary arterial hypertension.

Authors:  Eric D Austin; James E Loyd
Journal:  Circ Res       Date:  2014-06-20       Impact factor: 17.367

Review 7.  Update in pulmonary vascular diseases 2013.

Authors:  Paul M Hassoun; Paul T Schumacker
Journal:  Am J Respir Crit Care Med       Date:  2014-10-01       Impact factor: 21.405

8.  ATS Core Curriculum 2016. Part IV. Adult Pulmonary Medicine Core Curriculum.

Authors:  Gaëtane C Michaud; Colleen L Channick; Anica C Law; Jessica B McCannon; MaryEllen Antkowiak; Garth Garrison; David Sayah; Richard H Huynh; Anna K Brady; Rosemary Adamson; Hilary DuBrock; Praveen Akuthota; Chad Marion; Charles Dela Cruz; James A Town; Başak Çoruh; Carey C Thomson
Journal:  Ann Am Thorac Soc       Date:  2016-07

9.  A Semiconductor Chip-Based Next Generation Sequencing Procedure for the Main Pulmonary Hypertension Genes.

Authors:  Juan Gómez; Julian R Reguero; Celso Alvarez; Manuel R Junquera; Ana Arango; César Morís; Eliecer Coto
Journal:  Lung       Date:  2015-04-28       Impact factor: 2.584

Review 10.  Pulmonary arterial hypertension: pathogenesis and clinical management.

Authors:  Thenappan Thenappan; Mark L Ormiston; John J Ryan; Stephen L Archer
Journal:  BMJ       Date:  2018-03-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.